Get access

In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors’ insulin sensitivity in vivo

Authors

  • Anna-Maria Ordelheide,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Martin Heni,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Claus Thamer,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Fausto Machicao,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Andreas Fritsche,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    2. Division of Nutritional and Preventive Medicine, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Norbert Stefan,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Hans-Ulrich Häring,

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author
  • Harald Staiger

    1. Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, Member of the German Center for Diabetes Research (DZD e.V.), Eberhard Karls University Tübingen, Tübingen, Germany
    Search for more papers by this author

Abstract

Eur J Clin Invest 2011; 41 (12): 1323–1329

Abstract

Background  Peroxisome proliferator-activated receptor δ (PPARδ) activation enhances muscular fatty acid oxidation and oxidative phosphorylation, and muscle’s oxidative capacity positively associates with whole-body insulin sensitivity. Therefore, we asked here whether human muscle cell PPARD expression is a determinant of donors’ insulin sensitivity.

Materials and methods  Skeletal muscle cells derived from 38 nondiabetic donors were differentiated in vitro to myotubes, and gene (mRNA) expression was quantified by real-time RT–PCR. Donors’ insulin sensitivity was calculated from plasma insulin and glucose levels during oral glucose tolerance test (OGTT) and hyperinsulinemic-euglycemic clamp.

Results  Basal myotube PPARD expression was closely related to the expression of its target genes PDK4 and ANGPTL4 (P = 0·0312 and P = 0·0003, respectively). Basal PPARD, PDK4 and ANGPTL4 expression levels were not associated with donors’ insulin sensitivity (P > 0·2, all). Treatment of myotubes with a selective high-affinity PPARδ agonist (GW501516) did not change mean PPARD, but enhanced mean PDK4 and ANGPTL4 expression 13- and 16-fold, respectively (P < 0·0001, both). The individual PDK4 and ANGPTL4 expression levels reached upon GW501516 treatment were associated with donors’ insulin sensitivity neither (P > 0·2, both). However, GW501516-mediated fold increments in PDK4 and ANGPTL4 expression, reflecting PPARδ responsiveness, were positively associated with donors’ insulin sensitivity derived from OGTT (P = 0·0182 and P = 0·0231, respectively) and hyperinsulinemic-euglycemic clamp (P = 0·0046 and P = 0·0258, respectively).

Conclusions  Using a highly selective pharmacological tool, we show here that the individual responsiveness of human muscle cell PPARδ, rather than the absolute PPARD expression level, represents a major determinant of insulin sensitivity.

Get access to the full text of this article

Ancillary